Roots Analysis is pleased to announce the publication of its recent study, titled, “Patient Recruitment and Retention Services Market (3rd Edition), 2022 – 2035.”
The report features an extensive study of companies engaged in offering patient recruitment services and patient retention services. The study features an in-depth analysis of the key drivers and trends related to this domain. Amongst other elements, the report includes:
§ A general overview of the clinical trials, patient recruitment process, patient recruitment associated services as well as the patient retention strategies employed to prevent drop-out of enrolled individuals from clinical trials.
§ A brief information on the various types of patient outreach methods used by contract service providers in this domain, to identify and enroll patients in clinical trials.
§ A detailed assessment of the overall landscape of patient recruitment companies and patient retention companies offering these services.
§ A detailed competitiveness analysis of patient recruitment and retention service providers, segregated into three peer groups based on company size (small, mid-sized, and large and very large).
§ Elaborate profiles of prominent players offering patient recruitment and retention service, based in North America, Europe and Asia Pacific.
§ An analysis of the partnerships that have been inked by stakeholders engaged in this domain, from 2013-2022.
§ A review of the emerging trends in the patient recruitment industry, including the use of social media, mobile technologies, electronic health records (EHR), real-world evidence (RWE) and artificial intelligence.
§ A detailed discussion on the key growth opportunities in the field of patient recruitment and retention that are likely to impact the evolution of the market over the coming years.
§ A case study on regulatory landscape of patient recruitment, highlighting the regulatory process, guidelines and framework.
§ A brief overview of patient recruitment in clinical trials focused on personalized medicines and rare diseases.
§ A detailed analysis of the annual demand for study participants, taking into account the target patient population in ongoing and planned clinical trials, sponsored by both industry and non-industry players.
§ A detailed assessment on the impact of the COVID-19 pandemic on the patient recruitment and retention services market.
§ A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
§ Patient Recruitment Step
§ Pre-screening
§ Screening
§ Trial Phase
§ Phase I
§ Phase II
§ Phase III
§ Phase IV
§ Therapeutic Area
§ Cardiovascular Disorders
§ Oncological Disorders
§ Infectious Diseases
§ CNS Disorders
§ Respiratory Disorders
§ Hematological Disorders
§ Dermatological Disorders
§ Ophthalmic Disorders
§ Others
§ Key Geographical Regions
§ North America
§ Europe
§ Asia Pacific
§ Latin America
§ Middle East and North Africa
§ Rest of the World
Transcripts of interviews held with the following senior level representatives of stakeholder companies:
§ Susan Fitzpatrick-Napier (Founder and Director, TrialWire)
§ Kate Shaw (Chief Executive Officer and Founder) and Marco Lassandro (Marketing and Communications Manager, Innovative Trials)
§ Simon Klaasen (Co-founder and Managing Director, Link2Trials)
§ Stefan Mayer-Eggersmann (Chief Commercial Officer, Clariness)
§ Ken Shore (Chief Commercial Officer, Continuum Clinical)
§ Hagit Nof (Chief Operation Officer and Business Development Officer, nRollmed)
§ Paul Ivsin (Ex-Managing Director, Seeker Health)
§ Kasturi Lakhe (Inside Sales Specialist, EVERSANA)
Key companies covered in the report
§ BBK Worldwide
§ Continuum Clinical
§ IQVIA
§ United BioSource (UBC)
§ WCG ThreeWire
§ Clariness
§ Fidelis Research
§ Ignite Data
§ Innovative Trials
§ Orphan Reach
§ 3H Medi Solution
§ Buzzreach
§ Current Medical Information Center (CMIC)
§ nRollmed
§ Trialfacts
To view more details on this report, click on the link:
News article
Global Cell Free Expression Market
Learn from experts: do you know about these emerging industry trends? mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends |
4D Bioprinting Market: Key Trends
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
+44 (122) 391 1091
